SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-021050
Filing Date
2019-03-22
Accepted
2019-03-22 17:22:43
Documents
1
Period of Report
2019-03-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5058
  Complete submission text file 0001209191-19-021050.txt   6391
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Issuer) CIK: 0001087294 (see all company filings)

IRS No.: 000000000
SIC: 2834 Pharmaceutical Preparations

Mailing Address 31 UPPER MOUNTAIN AVENUE APARTMENT 2 MONTCLAIR NJ 07042
Business Address
Cearnal Martin E (Reporting) CIK: 0001408500 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33637 | Film No.: 19700742